CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Birmingham, Alabama, United States and 131 other locations
clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...
Phase 2
Homewood, Alabama, United States and 28 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Birmingham, Alabama, United States and 388 other locations
in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy results in an imp...
Phase 3
Homewood, Alabama, United States and 271 other locations
this study is to assess the safety, tolerability and preliminary efficacy of CC-94676 in men with progressive metastatic castration resistant prostate...
Phase 1
Birmingham, Alabama, United States and 24 other locations
The purpose of this study was to evaluate the efficacy of enzalutamide plus androgen deprivation therapy (ADT) as measured by radiographic progressio...
Phase 3
Homewood, Alabama, United States and 202 other locations
prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate...
Phase 3
Birmingham, Alabama, United States and 538 other locations
The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned t...
Phase 3
Birmingham, Alabama, United States and 559 other locations
The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination...
Phase 3
Birmingham, Alabama, United States and 313 other locations
The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progre...
Phase 3
Birmingham, Alabama, United States and 254 other locations
Clinical trials
Research sites
Resources
Legal